Menadione Topical Lotion

PreclinicalSmall molecule

Spectrum Pharmaceuticals, Inc

Menadione Topical Lotion is one of 55 small molecule programs targeting Cancer. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

CancerCompleted

CancerPreclinical

Completed

Competition

Competitive Landscape

58 competitors in Cancer

#DrugCompanyPhaseTrials

Vemlidy

Gilead

Approved

1 2

Lipitor

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 3

1 3

Keytruda

Merck & Co.

Phase 2

4 4

Tecentriq

Roche

Phase 2

4 5

Afinitor

Novartis

Phase 2

3 6

Cotellic

Roche

Phase 2

3 7

Herceptin

Roche

Phase 2

2 8

Lenvima

Eisai

Phase 2

2 9

Verzenio

Eli Lilly

Phase 2

2 10

Stivarga

Bayer

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Growth1 trial

Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash

Completed· Spectrum Pharmaceuticals, Inc logo

Spectrum Pharmaceuticals, Inc·Phase 1·NCT00656786·18 enrolled

Cancer1 trial

Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab

Completed·MMayo Clinic·N/A·NCT01393821·27 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Menadione Topical Lotion. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Menadione Topical Lotion compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Menadione Topical Lotion. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Spectrum Pharmaceuticals, Inc company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Spectrum Pharmaceuticals, Inc

Menadione Topical Lotion

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Growth1 trial

Cancer1 trial

References

Drug Info

Quick Facts

Related News